Division of Pulmonary & Critical Care Medicine, Gangneung Asan Hospital, Gangneung, Korea.
Int J Tuberc Lung Dis. 2010 Dec;14(12):1635-40.
South Korea, 2005-2007.
Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules (NTM-SPN) are rare and may be misdiagnosed as tuberculoma.
Eleven NTM-SPN patients were enrolled retrospectively and compared with two groups each of 33 patients with upper lobe cavitary (UC) and nodular bronchiectatic (NB) type NTM diseases, respectively.
The patients' median age was 52 years. Compared with UC-type disease, NTM-SPN patients showed female (n = 9) and never smoker (n = 8) predominance and fewer comorbidities (n = 0; P < 0.05 for each). Mycobacterium avium (n = 9) was predominant in NTM-SPN patients, followed by M. intracellulare (n = 2), whereas M. intracellulare was most frequently isolated from patients with both UC- and NB-type NTM (P < 0.05). The nodules were a median of 2.3 cm in diameter (range 1.6-6.3 cm) and were distributed evenly in all lobes. In all patients, percutaneous needle aspiration/biopsy was performed with a median 71 days of diagnostic delay. Ten patients successfully completed treatment, and one showed spontaneous reduction of nodule size without treatment. Reverse blot hybridisation assays of six DNA samples identified four subjects with M.avium-intracellulare complex (MAC), in line with conventional test data.
NTM-SPN was caused exclusively by MAC. Although clinical outcome was favourable, confirmatory diagnosis was delayed. Molecular methods are needed for early diagnosis of NTM-SPN.
2005-2007 年韩国。
非结核分枝杆菌病表现为孤立性肺结节(NTM-SPN)较为罕见,可能被误诊为结核瘤。
回顾性纳入 11 名 NTM-SPN 患者,并与每组各 33 例上叶空洞型(UC)和结节支气管扩张型(NB)NTM 疾病患者进行比较。
患者中位年龄为 52 岁。与 UC 型疾病相比,NTM-SPN 患者以女性(n = 9)和从不吸烟(n = 8)为主,合并症较少(n = 0;各 P < 0.05)。NTM-SPN 患者中以分枝杆菌鸟胞内复合群(n = 9)为主,其次是胞内分枝杆菌(n = 2),而 UC 和 NB 型 NTM 患者中最常分离出胞内分枝杆菌(P < 0.05)。结节直径中位数为 2.3 cm(范围 1.6-6.3 cm),分布于所有肺叶。所有患者均有经皮针吸活检,诊断延迟中位数为 71 天。10 例患者成功完成治疗,1 例未经治疗结节自行缩小。6 个 DNA 样本的反向斑点杂交分析鉴定出 4 例分枝杆菌鸟胞内复合群,与常规检测数据一致。
NTM-SPN 仅由 MAC 引起。尽管临床结局良好,但确诊时间延迟。需要分子方法来早期诊断 NTM-SPN。